A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. - Aubrey BJ; Blonquist T; McMasters M; Hobbs G; McAfee S; Rosenblatt J; Amrein P; Connolly C; Ramos A; Logan E; Dey B; Spitzer T; et al. (Leukemia research, 2025)